---
title: "Genprex shareholders approve amended 2018 equity incentive plan at annual meeting"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290240273.md"
description: "Genprex shareholders approved an amended 2018 equity incentive plan, increasing the share reserve by 1.85 million shares. The company also elected two new directors, ratified its independent auditor, and adopted a charter amendment authorizing a potential reverse stock split between 1-for-5 and 1-for-50 by December 31, 2027."
datetime: "2026-06-18T20:01:52.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290240273.md)
  - [en](https://longbridge.com/en/news/290240273.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290240273.md)
generator: "portal-rs"
---

# Genprex shareholders approve amended 2018 equity incentive plan at annual meeting

-   Genprex held its annual shareholder meeting on June 18, 2026. \* Shareholders elected Jose Antonio Moreno Toscano and Ryan M. Confer as directors with terms running to the 2029 annual meeting. \* WithumSmith+Brown was ratified as independent registered public accounting firm for fiscal 2026. \* An amended 2018 equity incentive plan was adopted, increasing the share reserve by 1,850,000; the plan became effective upon approval. \* A charter amendment authorizing a potential reverse stock split from 1-for-5 to 1-for-50 by Dec. 31, 2027 was adopted; implementation remains at the board’s discretion. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genprex Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-021134), on June 18, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [GNPX.US](https://longbridge.com/en/quote/GNPX.US.md)

## Related News & Research

- [Genprex signs CDMO deal to scale up manufacturing for diabetes gene therapy program](https://longbridge.com/en/news/296218198.md)
- [Exmar announces availability of 2026 half-year results release](https://longbridge.com/en/news/296992548.md)
- [Eiffage announces availability of H1 2026 results report](https://longbridge.com/en/news/297066901.md)
- [IBA publishes 2026 corporate brochure](https://longbridge.com/en/news/297018597.md)
- [AIxCrypto files draft Schedule 14C information statement for up to $50 million equity line](https://longbridge.com/en/news/296768441.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**